[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PE20050359A1 - Composiciones topicas que comprenden terbinafina e hidrocortisona - Google Patents

Composiciones topicas que comprenden terbinafina e hidrocortisona

Info

Publication number
PE20050359A1
PE20050359A1 PE2004000777A PE2004000777A PE20050359A1 PE 20050359 A1 PE20050359 A1 PE 20050359A1 PE 2004000777 A PE2004000777 A PE 2004000777A PE 2004000777 A PE2004000777 A PE 2004000777A PE 20050359 A1 PE20050359 A1 PE 20050359A1
Authority
PE
Peru
Prior art keywords
hydrocortisone
compositions including
topical compositions
gel
including terbinafine
Prior art date
Application number
PE2004000777A
Other languages
English (en)
Inventor
Catherine Larnier
Michel Steiger
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34717190&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20050359(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of PE20050359A1 publication Critical patent/PE20050359A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

REFERIDA A UNA COMPOSICION FARMACEUTICA PARA ADMINISTRACION TOPICA QUE COMPRENDE TERFINABINA EN PESO DE 0.1% A 10% O HIDROCORTISONA EN PESO DE 0.1% A 1.5% DE LA COMPOSICION TOTAL BAJO LA FORMA DE EMULSION-GEL, GEL, GEL DE ESPUMA, ENTRE OTRAS. DICHA COMPOSICION ES UTIL PARA ATACAR DERMATOFITOS
PE2004000777A 2003-08-12 2004-08-10 Composiciones topicas que comprenden terbinafina e hidrocortisona PE20050359A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03018271 2003-08-12

Publications (1)

Publication Number Publication Date
PE20050359A1 true PE20050359A1 (es) 2005-06-27

Family

ID=34717190

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000777A PE20050359A1 (es) 2003-08-12 2004-08-10 Composiciones topicas que comprenden terbinafina e hidrocortisona

Country Status (8)

Country Link
EP (1) EP1656125A2 (es)
JP (1) JP2007501832A (es)
AR (1) AR045241A1 (es)
AU (1) AU2004262934B2 (es)
CA (1) CA2535235A1 (es)
PE (1) PE20050359A1 (es)
TW (1) TW200511987A (es)
WO (1) WO2005013955A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
CN101262848B (zh) * 2005-09-29 2011-05-11 诺瓦提斯公司 抗真菌组合物
AU2006298748B2 (en) * 2005-09-29 2010-06-03 Karo Healthcare AB Antifungal composition
MXPA05012961A (es) * 2005-11-30 2007-05-30 Fernando Ahumada Ayala Preparaciones para el cuidado de las unas que contienen clorhidrato de terbinafina.
WO2008026381A1 (en) * 2006-08-28 2008-03-06 Hisamitsu Pharmaceutical Co., Inc. Nail patch
WO2008102349A2 (en) * 2007-02-21 2008-08-28 Power Paper Ltd Terbinafine formulation for iontophoresis
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2674563T3 (es) * 1999-04-23 2018-07-02 Leo Pharma A/S Pomada para el tratamiento tópico de la psoriasis

Also Published As

Publication number Publication date
JP2007501832A (ja) 2007-02-01
EP1656125A2 (en) 2006-05-17
AU2004262934B2 (en) 2007-11-29
TW200511987A (en) 2005-04-01
AR045241A1 (es) 2005-10-19
CA2535235A1 (en) 2005-02-17
WO2005013955A2 (en) 2005-02-17
WO2005013955A3 (en) 2005-04-28
AU2004262934A1 (en) 2005-02-17
WO2005013955A8 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
PE20080374A1 (es) Composiciones farmaceuticas de ropinirol
HN2005000484A (es) Nuevas composiciones farmaceuticas para el tratamiento de trastornos hiperproliferativos
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
HUP0302881A2 (hu) Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények
ECSP066970A (es) Preparaciones tópicas que contienen ambroxol
CR10732A (es) Uso de valerato de estradiol o 17 b- estradiol en combinacion con dienogest en una terapia oral para mantener y / o incrementar la libido femenina
BRPI0414883A (pt) composição, concentrado de composição, e, composições alcoólicas desinfetante e semelhante a gel
MX2010003923A (es) Formulacion farmaceutica de valsartan.
BRPI0617294B8 (pt) composição farmacêutica em gel hidroalcóolico e uso de testosterona
AR091606A1 (es) Composiciones orales de dentifrico y su uso en la fabricacion de un medicamento
MX2010005516A (es) Composiciones que comprenden al menos un derivado del acido naftoico, de peroxido de benzoilo y al menos un agente filmogeno.
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
UY28662A1 (es) Agente endoparasiticida para administracion topica
PE20080400A1 (es) Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas
BR0311327A (pt) Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo
AR058141A1 (es) Composiciones topicas de n,2,3 -trimetil-2- isopropilbutamida para el alivio del dolor y metodos para usarlas
PE20050359A1 (es) Composiciones topicas que comprenden terbinafina e hidrocortisona
RS51271B (sr) Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
ITMI20031640A1 (it) Base per gel bioadesivi.
BRPI0611526A2 (pt) composição tópica contendo gelatina
BRPI0508680A (pt) composição de resfriamento natural, composição flavorizante, produto pronto-para-consumo, e, uso de uma composição
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
AR060072A1 (es) Aerosoles dosificadores para la administracion de preparaciones farmaceuticas
BR0108958A (pt) Sistema de liberação controlada, administrado oralmente, para administração diária de ciprofloxacina
UY29403A1 (es) Composiciones farmacéutica sólida que comprende telitromicina.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed